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ABSTRACT 
Background: Human papillomavirus is the most 
prevalent sexually transmitted infection in the 
United States and is associated with 70% of 
cervical cancers as well as over 90% of genital 
warts. Although the HPV vaccine appears in the 
US immunization schedule during adolescence, 
a large percentage of women reach adulthood 
without being vaccinated. The Transtheoretical 
Model’s (TTM) Processes of Change (POC) con- 
struct provides an assessment of participants’ 
experiences with HPV vaccination and is a cen- 
tral component of computer-tailored interven- 
tions designed to increase compliance with me- 
dical recommendations, such as vaccination. 
This study describes development and valida- 
tion of a POC measure for increasing HPV vac- 
cination among young adult women. Methods: 
Cross-sectional measurement development was 
conducted using an online survey to reach a 
sample of 340 female college students repre- 
senting vaccinated and unvaccinated women. 
Factor analytic structural equation modeling as 
well as evaluations of the stage by POC were 
used to evaluate the validity of the POC measure. 
Results: Confirmatory analyses supported the 
theoretically expected ten-factor, fully correlated 
model as the best fit for the data. Expected 
Stage of Change to POC relationships were also 
confirmed insofar as each POC was significantly 
associated with Stage of Change, with the ex- 
ception of dramatic relief. Follow-up analyses 
suggested that individuals in the Precontempla- 
tion stage used all POC less frequently than in- 
dividuals in all other stages. Conclusions: The 
POC measure was found to be internally and 
externally valid in a sample of college-attending 
women. The POC measure developed may be 
used to tailor stage-matched interventions that 
increase use of experiential and behavioral stra- 
tegies important for increasing HPV vaccination 
in this high-risk population. 
 
Keywords: Human Papillomavirus;  
Transtheoretical Model; Processes of Change; 
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1. INTRODUCTION 
Human papillomavirus (HPV) is the most common 
sexually transmitted infection in the United States [1]. 
High-risk types of HPV (specifically 16 and 18) are as- 
sociated with 70% of cervical cancers diagnosed world- 
wide and low risk-types of HPV, such as types 6 and 11, 
are associated with 90% of genital warts cases [2]. It is 
estimated that 80% of sexually active females will be 
exposed to HPV before they reach 50 years of age [3]. 
Sexually active young women under 25 are at greatest 
risk for HPV infection and US prevalence of HPV has 
been shown to be highest among women aged 20 - 24 
[4-6]. Female college students have been identified as a 
high-risk population for HPV infection [7,8]. 
In June 2006, the Food and Drug Administration ap- 
proved GARDASIL®, a highly efficacious quadrivalent 
vaccine protective against HPV types 6, 11, 16, and 18 
[9]. GARDASIL® is a three dose vaccine series adminis- 
tered over six months. The American Committee on Im- 
munization Practices has recommended routine vaccina- 
tion of girls aged 11 - 12 and catches up vaccination of 
females aged 13 - 26 [10]. Routine vaccination of girls 
before sexual debut optimizes the protective benefit of 
the vaccine, but vaccinating girls and women older than 
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12 years of age may also help to reduce cervical cancer 
rates [11]. As of 2009, 44% of girls aged 13 - 17 reported 
receiving at least one dose of the vaccine series and 27% 
reported receipt of all three doses [12]. Data describing 
vaccine uptake levels among women over 17 years of 
age are limited, but the 2009 National Immunization Sur- 
vey found 17% of women aged 19 - 26 had received at 
least one dose of the HPV vaccine series [13]. Low vac- 
cine uptake among college-aged females requires further 
examination of variables that may influence vaccine 
acquisition and completion. 
One behavior change model particularly well-suited to 
examining motivation and decision-making related to 
HPV vaccination is the Transtheoretical Model of Change 
(TTM). The TTM is an integrative model of behavior 
change that has been applied to over 48 health behaviors 
[14]. It is organized around the Stages of Change and 
uses ten Processes of Change (POC) to represent activi- 
ties and experiences that are applied when engaging in 
intentional behavior change [15,16]. Stage of Change is 
comprised of five stages: Precontemplation (not intend- 
ing to change), Contemplation (considering change), and 
Preparation (preparing to make a change), Action (ac- 
tively engaged in behavior change), and Maintenance 
(sustaining change). Additional TTM constructs include 
Decisional Balance and Self-efficacy. Decisional Balance 
reflects the individual’s weighing of the pros and cons of 
changing their behavior [17]. Self-efficacy describes the 
individual’s situation specific confidence that they can 
sustain their behavior change despite high-risk or tempt- 
ing situations to relapse to their unhealthy behavior [18- 
20]. 
The POC represent the functional dimension of the 
TTM, outlining the experiential and behavioral ways in 
which people change [16,21,22]. There are ten POC, 
comprised of covert and overt activities representing two 
broad correlated experiential and behavioral domains. 
The experiential POC represent more covert cognitive 
and affective experiences/activities, and the behavioral 
POC represent more overt strategies, like substituting 
healthy alternatives, finding social support, and re- 
organizing the environment to promote behavior change 
(see Table 1). Unlike Decisional Balance which shows a 
high level of consistency across Stage of Change for 48 
health behaviors [14], the pattern of POC across be- 
haviors is less clear. In a comparison of 34 studies on 
smoking cessation, exercise, substance abuse, diet, and 
psychological problems, Rosen [23] found varying pat- 
terns of experiential and behavioral POC across health 
behaviors, but did not integrate the pattern of POC across 
all behaviors the way Hall and Rossi [14] did for the 
patterns of Decisional Balange across Stage of Change. 
Thus the consistency of POC across health behaviors 
remains unknown and it is important to conduct model  
Table 1. Processes of change. 
Process Name Description Mean SD 
Experiential Processes 
Consciousness 
Raising 
Efforts by the individual to 
gain awareness, gather 
information, or get feedback 
regarding the target behavior. 
11.31 3.74
Dramatic 
Relief 
Expression and experience of 
affect related to the target 
behavior (e.g. fear, hope, 
empowerment). 
12.31 4.40
Environmental 
Reevaluation 
Consideration of how the 
target behavior influences the 
physical and social 
environment. 
11.48 4.85
Self 
Reevaluation 
Cognitive and emotional 
reappraisal of one’s values 
related to the target behavior. 
12.36 4.50
Social 
Liberation 
Considering the social 
climate and norms related to 
the target behavior. 
12.58 4.15
Behavioral Processes 
Counter 
Conditioning 
Applying new ways of 
thinking and behaving to 
promote behavior change. 
10.34 4.51
Stimulus 
Control 
Strategic control of 
situations/triggers that may 
interfere with or promote 
behavior change. 
9.32 4.32
Self 
Liberation 
Commitment to change and  
belief in one’s ability to 
change. 
12.5 4.32
Reinforcement 
Management 
Application of behavioral 
contingencies to promote 
behavior change. 
10.85 4.45
Helping 
Relationships 
Use and availability of other 
people for social and 
emotional support while 
making a behavioral change. 
12.27 4.55
 
testing when applying the TTM to new behaviors. 
HPV vaccination is unique relative to other health be- 
haviors because it lacks a traditional behavioral Main- 
tenance stage and requires relatively little overt beha- 
vioral effort to reach the Action stage. Maintenance for 
HPV vaccination is effectively under biological control 
once the final dose of the vaccine is completed. People 
who achieve full-vaccination are no longer dependent on 
POC or relapse-prevention strategies that typically cha- 
racterize the Maintenance stage. For most behaviors 
(such as smoking) the decision to act (i.e. quit) can sig- 
nificantly increase the need for behavior controls to keep 
progressing and prevent relapse. However, one cannot 
relapse from vaccination, and thus the Action and Main- 
tenance stages are combined for this application of the 
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TTM to HPV vaccination. This staging modification has 
been successfully applied in organ donation research in 
the past [24,25], but this is the first published application 
of the Processes of Change to a behavior without a 
Maintenance stage. 
The aim of the current research was to conduct model 
testing for the TTM POC measure specific to HPV vac- 
cination among young adult women. This research also 
serves as an important part of the foundation for a future 
theory-based intervention. 
This project is part of a larger program of research that 
has already developed measures for Stages of Change, 
Decisional Balance, Self-efficacy, and knowledge related 
to HPV and HPV vaccination. This study extends this 
current program of research on HPV vaccination among 
adult women by 1) developing a POC measure specific 
to HPV vaccination in young adult women; 2) conduct- 
ing tests of external validation by examining patterns of 
POC across Stage of Change; and 3) and examining the 
relationships between the POC measure and other im- 
portant TTM constructs. 
2. METHODS 
2.1. Participants 
A sample of 340 female college students (aged 18 to 
26) representing a range of HPV vaccination experiences 
were recruited in the spring and summer of the recruit-
ment year. The modal age of participants was 18 and the 
median was 19. The sample was primarily white (76%). 
The mean GPA was 3.01 (SD = 0.52) and the majority of 
participants lived on campus (64%). The majority of par-
ticipants (93%) reported having health insurance. Among 
these individuals, just over half (59%) indicated that the 
HPV vaccine was covered by their insurance company, 
2% indicated it was not, and 39% indicated that they “did 
not know.” About half of the sample (50.3%) had re- 
ceived the full HPV vaccine series and were categorized 
in to the Action/Maintenance Stage. An additional 7.1% 
were in the Preparation stage, 11.2% were in the Con- 
templation stage, and 31.5% were in the Precontempla- 
tion stage. 
All participants were recruited through undergraduate 
introductory psychology courses, and e-mail list-serves 
at a mid-sized public university in the northeastern 
United States. Participants in earlier Stages of Change 
(pre-Action) were oversampled in order to procure an 
adequate number of participants in each Stage of Change. 
Participants were compensated with either class credit or 
a $20 gift card to a local business. Surveys were admin- 
istered online and accessed through a secure website sent 
to students by e-mail and/or psychology course websites. 
Participants were required to read the consent form and 
indicate agreement prior to accessing the survey. Human 
subject’s procedures were approved by the university’s 
institutional review board. 
2.2. Measurement Development Overview 
A three stage process of measurement development 
was used [26,27]. This procedure included item devel- 
opment and refinement using focus groups and expert 
reviews followed by structural equation modeling analy- 
ses to refine the POC scales and external validation with 
existing TTM measures [26-28]. As this was an effort to 
build a POC model for HPV vaccination, Confirmatory 
Factor Analysis (CFA) using Structural Equation Mod-
eling (SEM) was used as the primary model development 
analysis. SEM requires that the conceptualizations of a 
theory’s constructs be especially strong, with clearly de- 
fined and testable hypotheses as to how the constructs 
relate to one another. The POC model has been tested 
numerous times with other health behaviors [22,29-31]. 
The testing of various models against one another is an 
additional asset of CFA that is rarely practiced with other 
statistical techniques, and can further the understanding 
of how well a data set supports theoretical hypotheses. 
Ultimately, the retained model should be the one that fits 
the data best, both conceptually and empirically [28]. 
Initial Item Development and Refinement 
Initial item development and refinement was based on 
a review of the literature supplemented with expert con-
sultation, focus groups and cognitive interviews and fol-
lowed by pilot testing. Three 1.5-hour focus groups were 
conducted (N = 11). The primary purpose of these 
groups was to assess the HPV-related belief and attitudes 
of students and generate additional item content that may 
have been lacking in the literature. Once the items were 
finalized, five one-on-one cognitive interviews were con- 
ducted. The primary purpose of these interviews was to 
determine clarity and readability of the item pool and the 
instructions sets within the survey. All participants were 
undergraduate women ages 18 to 26 years old. 
2.3. Measures 
2.3.1. Stage of Change 
A short series of questions regarding past and present 
experience with the HPV vaccination was administered 
[32]. These questions were designed to place participants 
in one of four mutually exclusive categories for Stage of 
Change (Precontemplation, Contemplation, Preparation, 
and Action/Maintenance). Participants who reported fin- 
ishing the 3-shot vaccine series were categorized in the 
Action/Maintenance stage. Participants who were plan- 
ning to start the vaccination series within the next 30 
days (or complete within the next 6 months) were cate- 
gorized in the Preparation stage. Individuals who planned 
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on starting the vaccination within the next six months 
were categorized in the Contemplation stage, and those 
who had no intention of starting or finishing the vaccine 
series were classified in the Precontemplation stage. In- 
dividuals in the Precontemplation stage were asked an 
open-ended follow-up question regarding why they did 
not plan to start or complete the HPV vaccine series. 
Individuals in the Action/Maintenance stage were asked 
who recommended the HPV vaccine. Response options 
included Mother, Father, Yourself, Healthcare Provider/ 
Doctor, Other (Open-Ended). 
2.3.2. Decisional Balance 
The Decisional Balance scale consists of eight items, 
four to represent the pros (e.g., protecting myself from 
HPV would make me feel good) and four items to repre- 
sent the cons (e.g., it would be embarrassing to talk to 
my parents or doctor about getting vaccinated) of getting 
the HPV vaccine. Participants were asked to rate how 
important each item is in their decision of whether to get 
the vaccine. Response options were on a 5-point scale 
ranging from 1 “Not important at all” to 5 “Extremely 
important”. 
2.3.3. Self-Efficacy 
The Self-efficacy scale consists of six items aimed at 
measuring participants’ confidence in their ability to get 
the vaccine in situations that may prove challenging (e.g., 
when it is inconvenient). Responses were made on a 
5-point scale, ranging from 1 “Not at all confident” to 5 
“Extremely confident”. 
2.4. Analysis 
An iterative set of analyses was conducted utilizing 
structural equation measurement modeling. The aims of 
these analyses were to: 1) provide estimates of the factor 
loadings and 2) estimate internal consistency for each 
component using Cronbach’s alpha. Item selection was 
an iterative process, in which items with poor loadings 
(<0.40) were removed, and analyses were repeated. Final 
item selection was also determined on the basis of item 
clarity, lack of redundancy, and conceptual breadth. 
Once the final items were chosen, multiple measurement 
models were compared also using structural equation 
modeling. 
In order to determine the model of best fit, four fit in- 
dices were used: the likelihood ratio chi-square statistic, 
goodness of fit index (GFI), the comparative fit index 
(CFI), and the average absolute standardized residual 
statistic (AASR). Traditionally, values of 0.80 - 0.89 on 
the GFI and CFI indicate adequate to marginal fit, while 
values of 0.90 and above indicate good to excellent fit. 
For the AASR, values below 0.06 indicate excellent fit. 
More conservative criteria state that an acceptable GFI 
and CFI should be at least 0.90 while 0.95 and above 
indicate excellent fit. Factor loadings were assessed and 
retained above the adequate value of 0.40. 
The TTM hypothesizes that individuals in different 
Stages of Change will differ significantly on their scores 
for the Processes of Change subscales [22]. Multivariate 
Analysis of Variance (MANOVA) tests were conducted 
on all POC variables by Stage of Change. In order to fa- 
cilitate comparison in the magnitude of differences in 
scale scores among the different subscales and between 
the results of this study and previous studies examining 
TTM scales, raw scores were converted to T-scores 
(Mean = 50, standard deviation [SD] = 10). Correlations 
were examined to determine the relationship between 
each POC subscale and other TTM variables, including 
pros, cons, and Self-efficacy. 
3. RESULTS 
3.1. Initial Item Development and  
Refinement 
Literature reviews and focus groups were successful in 
conceptualizing and developing a total of 77 items re- 
flecting the 10 POC as they related to HPV vaccination 
among women. Items were further refined and clarified 
during cognitive interviews with participants. 
3.2. Descriptive Data 
Descriptive data gathered with reference to additional 
motivational influences related to HPV vaccination re- 
vealed that among those who were vaccinated (in the 
Action/Maintenance Stage) 63% reported that the vac- 
cine was recommended to them by a doctor or other 
health care provider, 28% by their mother, 6% self- 
recommended, 1% by their father, and <1% by their high 
school or college. Participants who were not intending to 
start or finish the vaccine in the next six months gave a 
variety of reasons as to why they were not planning on 
receiving the vaccine. The largest proportion of students 
indicated fear of risks or side effects (24%). Many indi- 
viduals (14.6%) felt they did not have adequate knowl- 
edge or were undecided about vaccination Additional 
reasons included a lack of perceived need or personal 
risk (14.6%), lack of time/motivation (11.5%), believing 
that the vaccine was too new and insufficient research 
had been conducted (11.5%), moral/personal reasons 
(8.3%), being told not to get the shot by a parent or doc- 
tor (6.3%), logistical barriers such as cost/access (5.2%), 
and fear of shots (3.1%). 
Measure Development 
Seventy-seven items were included in the confirma- 
tory structural equation modeling analysis for this meas- 
ure. Diagnostic indicators provided by the analysis were 
Copyright © 2013 SciRes.                                                                    OPEN ACCESS 
A. C. Fernandez et al. / Open Journal of Preventive Medicine 3 (2013) 301-309 305
used to detect poorly functioning items. Four items with 
low loadings (<0.40) on their respective factors were 
deleted. With these items removed the modeling was re- 
peated and further item deletions were made based on 
item loading, item complexity, and breadth of construct. 
These procedures ultimately reduced the number of items 
from 77 to 40 (4 items per process). Scale means and 
standard deviations can be seen in Table 1. 
Two models were tested: 1) null model (suggesting no 
latent factors and used as a comparative model) and 2) 
ten correlated factor model. The ten-factor correlated 
model demonstrated the best fit to the data, 2 (695) = 
2185.48, p < 0.001; CFI = 0.87, GFI = 0.74 and AASR = 
0.043. Standardized factor loadings for each item are 
displayed in Figure 1. The internal consistencies were 
good, with Cronbach’s alphas ranging from 0.76 to 0.92. 
3.3. External Validation 
The results of the MANOVA examining scores on the 
ten POC across the Stages of Change were F (30,960) = 
4.72, p < 0.001, η2 = 0.13. Follow-up ANOVAs revealed 
that each of the POC subscales was significantly associ- 
ated with Stages of Change (p value’s < 0.001), with the 
exception of Dramatic Relief (p = 0.09). Inspection of 
the POC means across Stage of Change using follow-up 
Tukey tests revealed that individuals in the Precontem- 
plation stage used all POC less than individuals in all 
other stages (p value’s < 0.05) (see Figures 2 and 3). 
Effect sizes computed for change in POC from Precon- 
templation to Contemplation ranged from d = 0.38 to d = 
0.75. These are medium to large in magnitude [33]. 
Mean differences across the later Stages of Change 
(e.g. Contemplation to Preparation) were not significant. 
Despite null findings, effects sizes observed for change 
in Social Liberation (d = 0.31) and Stimulus Control (d = 
0.30) from Contemplation to Preparation, do not rule out 
the possibility of clinically meaningful change. 
The correlations among the POC subscales (experien- 
tial and behavioral), Decisional Balance, and Self-effi- 
cacy were examined. As can be seen in Table 2, the ex- 
periential and behavioral POC were strongly positively 
correlated with one another and moderately correlated 
 
Table 2. Correlations between processes of change and other 
TTM constructs. 
 Behavioral  Processes Pros Cons Self-Efficacy
Experiential Processes 0.903** 0.467** 0.064 0.253** 
Behavioral Processes  -- 0.398** 0.044 0.279** 
Pros   -- 0.016 0.276** 
Cons    -- −0.022 
Self-Efficacy    -- 
**p < 0.01 level (2-tailed). 
with Pros and Self-efficacy. Cons of seeking the vaccine 
were not correlated any of the other constructs for HPV 
vaccination. 
 
4. DISCUSSION 
The primary objective of this study was to develop a 
reliable and valid measure of the Processes of Change 
applied to HPV vaccination among young, adult, col- 
lege-attending women. Results indicate that the POC 
measure is reliable and has a stable factor structure. The 
hypothesized correlated ten-factor structure was sup- 
ported. 
Similar to previous TTM research, our findings indi- 
cate that the POC were used least by individuals in the 
Precontemplation stage. This is consistent with past re- 
search and theory [34] indicating that Precontemplators 
traditionally score lowest on the majority of POC be- 
cause they are least ready to change their thoughts and 
actions regarding a given behavior [19,21]. The steepest 
increase in use of all POC occurred between the Precon- 
templation and Contemplation stages. The observed ef- 
fect sizes for these increases were medium to large in 
magnitude. These findings coincide with research indi- 
cating that across health behaviors a large proportion of 
between stage variance is accounted for by the difference 
between Precontemplation and all other stages combined 
(typically, 70% for experiential POC and 50% for be- 
havioral POC) [23]. The early and parallel increase in 
experiential and behavioral POC suggests that for HPV 
vaccination cognitive and affective experiences coincide 
with strategic use of personal, social, and environmental 
resources to promote behavior change. 
Clinically, this research can be used to help develop 
TTM tailored interventions by identifying POC that are 
emphasized the most or least at particular Stages of 
Change. While the patterns did not reach statistical sig- 
nificance, Dramatic Relief, was the process emphasized 
most in Precontemplation but the least in Action/Main- 
tenance. Self-reevaluation, was emphasized the least in 
Precontemplation but the most in Preparation. In terms of 
behavioral POC, Stimulus Control and Reinforcement 
Management, were emphasized least in Precontempla- 
tion but most in Action/Maintenance indicating the need 
for women in later stages to receive feedback on how to 
manage stimuli and environmental contingences to com- 
plete the vaccine series. Additional research using a lar- 
ger sample is needed to confirm these findings. 
This study also reported correlations between POC 
and other TTM constructs for which relevant published 
comparisons are unavailable. Our findings indicated that 
the experiential and behavioral POC were positively 
correlated with pros and Self-efficacy. These positive 
correlations are consistent with TTM theory, which in- 
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Figure 1. HPV vaccine acquisition processes of change structural mode. CR = Consciousness Raising, DR = Dramatic Relief, ER = 
Environmental Reevaluation, SR = Self Reevaluation, SO = Social Liberation, CC = Counter Conditioning, SC = Stimulus Control, 
HR = Helping Relationships, RM = Reinforcement Management, SL = Self Liberation. 
 
dicates that a greater number and/or broader range of 
experiential and behavioral mechanisms are utilized by 
individuals in later Stages of Change when pros and Self- 
efficacy are also increasing. 
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Figure 2. Experiential processes of change X stage of change. 
 
 
Figure 3. Behavioral processes of change X stage of change. 
PC = Precontemplation, C = Contemplation, PR = Preparation, 
A/M = Action/Maintenance CR = Consciousness Raising, DR 
= Dramatic Relief, ER = Environmental Reeavaluation, SR = 
Self Reevaluation, SO = Social Liberation, CC = Counter Con- 
ditioning, SC = Stimulus Control,  HR = Helping Relation- 
ships, RM = Reinforcement Mangagement, SL = Self Liber- 
ation. 
 
Based on these correlations, the experiential POC ac- 
counted for 21.8% of variance in pros but less than 7% 
of Self-efficacy. This finding indicates the decision to 
receive the HPV vaccination may emphasize cognitive 
processes and perceived advantages of vaccination, ra- 
ther than confidence in one’s ability to carry out a be- 
havior. The finding that POC is related to pros but not 
cons suggests that future interventions’ emphasis should 
perhaps be placed on the POC that have the highest cor- 
relations with the Pros. 
Limitations of this study include the use of a single 
sample of predominantly white college students residing 
in the Northeastern United States. Although results of the 
current research indicate adequate scale reliability and 
factor stability, further validation is needed among a 
more diverse sample of young adult women in terms of 
geography, education, race, and ethnicity. Replication of 
these findings across diverse samples will provide further 
evidence of internal and external validity. 
Our findings underscore the need for HPV vaccination 
interventions for women in the earliest Stages of Change 
when POC need to increase the most. Over 63% of un- 
vaccinated women in this study were in Precontempla- 
tion Stage, and 9 out of 10 POC increased significantly 
between Precontemplation and Contemplation. TTM- 
tailored interventions should focus on increasing the use 
of all POC among individuals in the Precontemplation 
Stage, and maintaining the use of POC until vaccination 
is complete. This can be done strategically through inter- 
ventions that use tailoring to accelerate an individual’s 
progress through the Stages of Change [35]. The POC 
measure validated in this study offers 40 items that could 
provide innovative behavioral and experiential tactics for 
producing behavior change. Another direction for inter- 
vention efforts is to utilize health care providers or clin- 
ics to deliver change-related messages. In this study the 
most common source cited for vaccination recommenda- 
tion was health care providers. The most common reason 
not to get vaccinated was fear of vaccine-related risks 
and side-effects. 
The current research in combination with several other 
published reports on TTM measurement development for 
HPV vaccination [32,36] can provide a foundation for 
developing a TTM-tailored intervention to increase HPV 
vaccination among young adult women. Due to low rates 
of vaccination among this population, the need for em- 
pirically-based, easily disseminated interventions is clear. 
The current study represents a first step in developing 
such an intervention and provides initial guidelines for 
applying POC across Stage of Change. 
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